KYMR ▲ +5.0% - Kymera Therapeutics, Inc.
$KYMR - Kymera Therapeutics to Announce KT-621 BROADEN2 Phase 2b Atopic Dermatitis Trial Results on November 23, 2026
20-NOV-2026 04:01 PM ET
Share this post
More filings for $KYMR
KYMR ▼ -0.5% - Kymera Therapeutics, Inc.Oct 29, 2026KYMR ▲ +4.6% - Kymera Therapeutics, Inc.Oct 28, 2026KYMR - Kymera Therapeutics, Inc. - SEC Filing Update (27-OCT-2026) | ThinkSabio - Stocks SimplifiedOct 27, 2026KYMR ▼ -1.6% - Kymera Therapeutics, Inc.Oct 22, 2026KYMR ▲ +3.1% - Kymera Therapeutics, Inc.Sep 10, 2026KYMR - Kymera Therapeutics, Inc. - SEC Filing Update (08-SEP-2026) | ThinkSabio - Stocks SimplifiedSep 8, 2026
View full $KYMR filing history →💬 Comments
Loading comments…
Leave a comment
